A nurse is collecting data from a client who is 18 hr postpartum. The nurse notes that the client is in the "taking-in phase" of maternal adjustment. Which of the following manifestations should the nurse expect?

Choice A Reason:

Time of last pain medication is correct. This is important for the oncoming nurse to know to ensure timely pain management for the client.

Choice B Reason:

Preferred bath time is incorrect. While it's important to respect the client's preferences, the timing of their bath is typically not as critical to include in the change-of-shift report, especially when compared to more vital information like medication timing.

Choice C Reason:

Admission vital signs is incorrect. Vital signs taken upon admission are usually documented in the client's chart and are not typically included in change-of-shift reports unless there has been a significant change or concern with the client's vital signs during the shift.

Choice D Reason:

Steps required for dressing change is incorrect. While important for the client's care, the specific steps for a dressing change are typically documented in the client's care plan or orders and may not need to be repeated in every shift report unless there's a specific issue or change in the dressing change procedure.

Choice A Reason:

Improved respiratory function is incorrect. Pancrelipase primarily helps with the digestion and absorption of fats and fat-soluble vitamins. It does not directly impact respiratory function. Respiratory improvement in cystic fibrosis typically involves treatments such as airway clearance techniques, bronchodilators, and antibiotics to manage lung infections.

Choice B Reason:

Reduced fat in the stools is correct. Pancrelipase is an enzyme replacement therapy used to treat individuals with cystic fibrosis, a condition that affects the pancreas's ability to produce digestive enzymes. Cystic fibrosis leads to the malabsorption of nutrients, especially fats. Pancrelipase supplements these digestive enzymes and helps the child digest and absorb fat properly. As a result, one of the expected therapeutic effects of pancrelipase is a reduction in fat in the stools, as the enzymes aid in the digestion of dietary fats, leading to improved absorption of nutrients. This, in turn, can help address malnutrition and promote overall health in individuals with cystic fibrosis.

Choice C Reason:

Improved absorption of vitamins B and C is incorrect. While pancrelipase can help with the absorption of fat-soluble vitamins (A, D, E, and K), it does not directly affect the absorption of vitamins B and C, which are water-soluble vitamins. Cystic fibrosis primarily affects the absorption of fat-soluble vitamins due to impaired fat digestion.

Choice D Reason:

Decreased sodium excretion is incorrect. Cystic fibrosis is associated with excessive loss of salt (sodium chloride) in sweat. Pancrelipase does not directly affect sodium excretion. Treatment for managing sodium loss typically involves salt supplementation and ensuring proper hydration.